BCAX — BICARA THERAPEUTICS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in BICARA THERAPEUTICS INC (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.74% (2025 Q3)
Avg. % of fund
2.41%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 175,902 -13,797 -7.3% 2.74% $2.8M $15.79
2025 Q2 INITIATED 189,699 — — 2.09% $1.8M $9.29
% of Fund (quarterly)    BCAX price (monthly, adj. close)

Other funds also holding BCAX

As of 2025 Q4 — sorted by position size

Omega Fund Management, LLC 3Y 7Y 12.95% ACORN CAPITAL ADVISORS, LLC 3.67% Siren, L.L.C. 2.62% Vestal Point Capital, LP 2.05% Aisling Capital Management LP 3Y 7Y 2.0% TPG GP A, LLC 3Y 1.89% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.2% DAFNA Capital Management LLC 3Y 7Y 1.02% Deep Track Capital, LP 3Y 0.78% Palo Alto Investors LP 3Y 7Y 0.7%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings